1 1 1 1 1 1 1 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
A more a A A A A BLOCKIN PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 0 0 :- 2 10 0 0 0 0 1
organoids assessment organoids o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 2 0 0 0 0 1
Silvia Cruz-Gil silvia S Si Sil Silv BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 -,.-,-,.,. 10 10 0 0 0 0 1
Sebastian Schölch sebastian S Se Seb Seba BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 2 ,,,..,*. 8 10 0 0 0 0 1
1 Molecular 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 /,,., 5 10 0 0 0 0 1
8 E-28049 8 8 8 8 8 BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 5 -,. 3 10 0 0 0 0 1
2 Department 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 5 ,, 2 10 0 0 0 0 1
Carus, Technische carus, C Ca Car Caru BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 ,,,,. 5 10 0 0 0 0 1
3 Medizinische 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 7 ,-- 3 10 0 0 0 0 1
Heidelberg, Theodor-Kutzer-Ufer heidelberg, H He Hei Heid BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 ,---, 5 10 0 1 0 0 1
4 German 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 8 () 2 10 0 1 0 0 1
5 German 5 5 5 5 5 BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 9 (),, 4 10 0 1 0 0 1
* Correspondence * * * * * BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 9 *..(-:.@.). 11 10 0 1 0 0 1
Running head running R Ru Run Runn BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 no 0 10 0 1 0 0 1
Handling organoids handling H Ha Han Hand BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 -. 2 10 0 1 0 0 1
2 2 2 2 2 2 2 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Precision medicine precision P Pr Pre Prec BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
anticancer drug anticancer a an ant anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ().,, 5 10 0 0 0 0 1
application need application a ap app appl BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ., 2 10 0 0 0 0 1
imply a imply i im imp impl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 , 1 10 0 0 0 0 1
personalized treatment personalized p pe per pers BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 -.- 3 10 0 0 0 0 1
related axis, related r re rel rela BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ,/, 3 10 0 0 0 0 1
the invasive the t th the the BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ; 1 10 0 0 0 0 1
checked ACSL/SCD checked c ch che chec BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 /, 2 10 0 0 0 0 1
organoids as organoids o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 10 0 0 0 0 1
upregulated in upregulated u up upr upre BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -,, 3 10 0 0 0 0 1
stages. Besides, stages. s st sta stag BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .,() 4 10 0 0 0 0 1
Metformin than metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 (-). 4 10 0 0 0 0 1
an independent an a an an an BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 6 "" 2 10 0 0 0 0 1
cell markers cell c ce cel cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 10 0 0 0 0 1
the use the t th the the BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 10 0 0 0 0 1
Keywords: CRC-like keywords: K Ke Key Keyw BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 :-,,/,,- 8 10 0 0 0 0 1
synthetases, Stearoyl-CoA synthetases, s sy syn synt BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 ,-,,,-, 7 10 0 0 0 0 1
personalized medicine. personalized p pe per pers BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 . 1 10 0 0 0 0 1
Abbreviations: ACSL1: abbreviations: A Ab Abb Abbr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 ::-;:-;: 8 10 0 0 0 0 1
Colorectal cancer; colorectal C Co Col Colo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 ;:-;-:;/: 9 10 0 0 0 0 1
MicroRNAs; MTT: micrornas; M Mi Mic Micr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 ;:-(,---)-,-;: 14 10 0 0 0 0 1
Oxaloacetate; SCD: oxaloacetate; O Ox Oxa Oxal BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ;:-;:;:- 8 10 0 0 0 0 1
dimensional; 3D: dimensional; d di dim dime BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 ;:-. 4 10 0 0 0 0 0
3 3 3 3 3 3 3 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Colorectal cancer colorectal C Co Col Colo BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ()(), 5 10 0 0 0 0 1
and prostate and a an and and BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,(.),[]. 8 10 0 0 0 0 1
the CRC the t th the the BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (-), 4 10 0 0 0 0 1
in which in i in in in BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 2 .(-) 4 10 0 0 0 0 1
those among those t th tho thos BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,,[]., 6 10 0 0 0 0 1
sporadic CRC sporadic s sp spo spor BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
and oncogenes and a an and and BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 [,].-, 6 10 0 0 0 0 1
which specific which w wh whi whic BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ; 1 10 0 0 0 0 1
Vogelstein (Vogelgram). vogelstein V Vo Vog Voge BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 ().- 4 10 0 0 0 0 1
would start would w wo wou woul BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,, 2 10 0 0 0 0 1
or loss or o or or or BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ()[]. 5 10 0 0 0 0 1
Over the over O Ov Ove Over BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 10 0 0 0 0 1
expansively increased. expansively e ex exp expa BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 10 0 0 0 0 1
is the is i is is is BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ;, 2 10 0 0 0 0 1
are not are a ar are are BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 10 0 0 0 0 1
denoted as denoted d de den deno BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 "". 3 10 0 0 0 0 1
Even though even E Ev Eve Even BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 - 1 10 0 0 0 0 1
catabolic pathways, catabolic c ca cat cata BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 ,- 2 10 0 0 0 0 1
with a with w wi wit with BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ./[], 5 10 0 0 0 0 1
metabolism-related network metabolism-related m me met meta BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 -- 2 10 0 0 0 0 1
mesenchymal transition mesenchymal m me mes mese BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 () 2 10 0 0 0 0 1
cells. The cells. c ce cel cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 . 1 10 0 0 0 0 0
through reactivation through t th thr thro BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 --, 3 10 0 0 0 0 0
Metformin. Though metformin. M Me Met Metf BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ., 2 10 0 0 0 0 0
4 4 4 4 4 4 4 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 0 0 0 0
robust anti-proliferative robust r ro rob robu BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -,,, 4 10 0 1 0 0 1
ovarian, prostate ovarian, o ov ova ovar BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,[]., 5 10 0 1 0 0 1
with improved with w wi wit with BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ,, 2 10 0 0 0 0 1
has not has h ha has has BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 [] 2 10 0 0 0 0 1
The ACSL/SCD the T Th The The BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 /-- 3 10 0 0 0 0 1
regulated by regulated r re reg regu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 .-,-,-- 7 10 0 0 0 0 1
regulators of regulators r re reg regu BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 /--- 4 10 0 0 0 0 1
associated with associated a as ass asso BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 ,/ 2 10 0 0 0 0 1
in patients in i in in in BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 4 []. 3 10 0 0 0 0 1
To get to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
ACSL/SCD axis acsl/scd A AC ACS ACSL BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 /, 2 10 0 0 0 0 1
tools are tools t to too tool BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 no 0 10 0 0 0 0 1
cultures. In cultures. c cu cul cult BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ., 2 10 0 0 0 0 1
studies. studies. studies. s st stu stud BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 10 0 0 0 0 1
Adult tissue-derived adult A Ad Adu Adul BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 -,""[]- 7 10 0 0 0 0 1
structures derived structures s st str stru BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
composition and composition c co com comp BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 []. 3 10 0 0 0 0 1
established in established e es est esta BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 10 0 0 0 0 1
organoids with organoids o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 -- 2 10 0 0 0 0 1
differentiated cells differentiated d di dif diff BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 []. 3 10 0 0 0 0 1
The organoids the T Th The The BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 -. 2 10 0 0 0 0 1
Organoids starts organoids O Or Org Orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 , 1 10 0 0 0 0 1
finally will finally f fi fin fina BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 . 1 10 0 0 0 0 0
formed by formed f fo for form BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 []. 3 10 0 0 0 0 0
5 5 5 5 5 5 5 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 0 0 0 0
Organoids are organoids O Or Org Orga BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 0 1 0 0 1
[12,13]. Along [12,13]. [ [1 [12 [12, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 [,]., 5 10 0 1 0 0 1
mouse and mouse m mo mou mous BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 [-]- 4 10 0 0 0 0 1
derived organoids derived d de der deri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ., 2 10 0 0 0 0 1
without any without w wi wit with BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,- 2 10 0 0 0 0 1
leads to leads l le lea lead BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 []. 3 10 0 0 0 0 1
6 6 6 6 6 6 6 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 1 0 0 0
Materials and materials M Ma Mat Mate BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 0 0 0 0 1
CRC-like organoids: crc-like C CR CRC CRC- BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -: 2 10 0 0 0 0 1
Mice: Mutant mice: M Mi Mic Mice BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 : 1 10 0 0 0 0 1
Gustav Carus, gustav G Gu Gus Gust BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 1 1 ,. 2 10 0 0 0 0 1
with FELASA with w wi wit with BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 10 0 0 0 0 1
Universität Dresden universität U Un Uni Univ BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 2 . 1 10 0 0 0 0 1
Mice with mice M Mi Mic Mice BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 ,, 2 10 0 0 0 0 1
Mouse Repository mouse M Mo Mou Mous BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 (,)() 5 10 0 0 0 0 1
compound mutant compound c co com comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ().-- 5 10 0 0 0 0 1
carcinoma sequence carcinoma c ca car carc BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 :/, 3 10 0 0 0 0 1
KRAS G12D/WT kras K KR KRA KRAS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 /,//()(). 9 10 0 1 0 0 1
mouse lines mouse m mo mou mous BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 10 0 1 0 0 1
Table 1: table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 : 1 10 0 1 0 0 1
Mutation Mutation mutation M Mu Mut Muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 1 0 1 0 0 1
Designation Designation designation D De Des Desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 1 0 1 0 0 1
PMID PMID pmid P PM PMI PMID BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 0 0 1 0 0 1
APC APC apc A AP APC APC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 0 0 1 0 0 1
NCI: 01XAA nci: N NC NCI NCI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 : 1 1 0 1 0 0 1
17002498 17002498 17002498 1 17 170 1700 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 7 no 0 1 0 1 0 0 1
KRAS G12D kras K KR KRA KRAS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 1 0 1 0 0 1
JAX: 008179 jax: J JA JAX JAX: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 : 1 1 0 1 0 0 1
11323676 11323676 11323676 1 11 113 1132 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 7 no 0 1 0 1 0 0 1
P53 R172H p53 P P5 P53 P53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 no 0 1 0 1 0 0 1
JAX: 008652 jax: J JA JAX JAX: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 : 1 1 0 1 0 0 1
15607980 15607980 15607980 1 15 156 1560 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 7 no 0 1 0 1 0 0 1
P53 floxed p53 P P5 P53 P53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 no 0 1 0 1 0 0 1
NCI: 01XC2 nci: N NC NCI NCI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 : 1 1 0 1 0 0 1
11694875 11694875 11694875 1 11 116 1169 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 7 no 0 1 0 1 0 0 1
Smad4 floxed smad4 S Sm Sma Smad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 no 0 1 0 1 0 0 1
JAX: 017462 jax: J JA JAX JAX: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 : 1 1 0 1 0 0 1
11857783 11857783 11857783 1 11 118 1185 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 7 no 0 1 0 1 0 0 1
Table 2: table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 :-. 3 10 0 1 0 0 1
Organoid mutation organoid O Or Org Orga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 2 0 1 0 0 1
CRC-like stage crc-like C CR CRC CRC- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 - 1 1 0 1 0 0 1
WT WT wt W WT WT WT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 0 0 1 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 - 1 0 0 1 0 0 1
APC fl/fl apc A AP APC APC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 / 1 1 0 1 0 0 1
I I i I I I I BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 0 0 1 0 0 1
APC fl/fl apc A AP APC APC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 /,/ 3 3 0 1 0 0 1
II II ii I II II II BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 0 0 1 0 0 1
APC fl/fl apc A AP APC APC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 /,/,/ 5 5 0 1 0 0 1
III III iii I II III III BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 0 0 1 0 0 1
APC fl/fl apc A AP APC APC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 /,/,/,/ 7 6 0 1 0 0 1
IV IV iv I IV IV IV BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 0 0 1 0 0 1
7 7 7 7 7 7 7 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 0 0 0 0
Murine organoids murine M Mu Mur Muri BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 /. 2 10 0 1 0 0 1
were performed were w we wer were BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 []. 3 10 0 1 0 0 1
Crypt isolation crypt C Cr Cry Cryp BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 : 1 10 0 0 0 0 1
intestine by intestine i in int inte BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 10 0 0 0 0 1
[11,19]. Isolated [11,19]. [ [1 [11 [11, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 [,].(). 7 10 0 0 0 0 1
medium (Advanced medium m me med medi BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ('/ 3 10 0 0 0 0 1
penicillin/streptomycin, 10 penicillin/streptomycin, p pe pen peni BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 /,/,[],) 8 10 0 0 0 0 1
supplemented with: supplemented s su sup supp BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 :/(),-(, 8 10 0 0 0 0 1
volume), 1x volume), v vo vol volu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ),(),(),,-(-), 14 10 0 0 0 0 1
100 μg/mL 100 1 10 100 100 BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 4 /()/(). 7 10 0 0 0 0 1
is named is i is is is BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ., 2 10 0 0 0 0 1
and mechanically and a an and and BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 10 0 0 0 0 1
[11,14,20]. Splitting [11,14,20]. [ [1 [11 [11, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 [,,].:., 8 10 0 0 0 0 1
5% CO2 5% 5 5% 5% 5% BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 . 1 10 0 0 0 0 1
Drugs treatment drugs D Dr Dru Drug BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 - 1 10 0 0 0 0 1
Cell viability cell C Ce Cel Cell BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 - 1 10 0 0 0 0 1
plates. After plates. p pl pla plat BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 .,() 4 10 0 0 0 0 1
10, 100 10, 1 10 10, 10, BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 ,-(),. 6 10 0 0 0 0 1
At this at A At At At BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 ,, 2 10 0 0 0 0 1
in supplemented in i in in in BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 9 . 1 10 0 0 0 0 1
Upon treatments upon U Up Upo Upon BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 ()(-),- 7 10 0 0 0 0 1
(4,5-dimethyl-thyazol-2-yl)-2,5-diphenyl-tetrazolium (MTT, (4,5-dimethyl-thyazol-2-yl)-2,5-diphenyl-tetrazolium ( (4 (4, (4,5 BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 (,----)-,--(,)., 16 10 0 0 0 0 1
20 μl 20 2 20 20 20 BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 ()(,). 6 10 0 0 0 0 0
8 8 8 8 8 8 8 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 0
resultant formazan resultant r re res resu BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 10 0 1 0 0 1
measured on measured m me mea meas BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,). 4 10 0 1 0 0 1
Untreated organoids untreated U Un Unt Untr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 10 0 0 0 0 1
viable cells viable v vi via viab BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -. 2 10 0 0 0 0 1
RNA isolation rna R RN RNA RNA BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 - 1 10 0 0 0 0 1
For RNA for F Fo For For BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 ,()() 5 10 0 0 0 0 1
and pelleted and a an and and BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 . 1 10 0 0 0 0 1
carefully resuspended carefully c ca car care BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (),-. 5 10 0 0 0 0 1
the supplier's the t th the the BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 '()(/) 6 10 0 0 0 0 1
determined by determined d de det dete BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ( 1 10 0 0 0 0 1
ThermoScientific). 20 thermoscientific). T Th The Ther BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 )./--- 6 10 0 0 0 0 1
cDNA kit cdna c cD cDN cDNA BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 (),'. 5 10 0 0 0 0 1
was measured was w wa was was BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()(). 5 10 0 0 0 0 1
are listed are a ar are are BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ., 2 10 0 0 0 0 1
MicroRNA Reverse microrna M Mi Mic Micr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 ()- 3 10 0 0 0 0 1
RT-qPCR (S2 rt-qpcr R RT RT- RT-q BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 -().-( 6 10 0 0 0 0 1
Biosystems) and biosystems) B Bi Bio Bios BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 )- 2 10 0 0 0 0 1
expression. expression. expression. e ex exp expr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 . 1 10 0 0 0 0 1
L-Lactate quantification l-lactate L L- L-L L-La BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 - 1 10 0 0 0 0 1
Organoids were organoids O Or Org Orga BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 -., 3 10 0 0 0 0 1
medium was medium m me med medi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,- 2 10 0 0 0 0 1
media overnight media m me med medi BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 .'- 3 10 0 0 0 0 1
(Cayman, Ann (cayman, ( (C (Ca (Cay BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 (,,,,)- 7 10 0 0 0 0 0
absorbance at absorbance a ab abs abso BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 .-() 4 10 0 0 0 0 0
concentration (mg) concentration c co con conc BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 (). 3 10 0 0 0 0 0
9 9 9 9 9 9 9 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 0
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
All statistical all A Al All All BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 (..)( 5 10 0 0 0 0 1
Software, San software, S So Sof Soft BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 ,,,).- 6 10 0 0 0 0 1
(unpaired Student's (unpaired ( (u (un (unp BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ('-)..(, 8 10 0 0 0 0 1
0.05; *, 0.05; 0 0. 0.0 0.05 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .;*,.;**,.;***,.;****,.). 25 10 0 0 0 0 1
two-sided. All two-sided. t tw two two- BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 -... 4 10 0 0 0 0 1
10 10 10 1 10 10 10 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 0
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 10 0 1 0 0 1
ACSL4 is acsl4 A AC ACS ACSL BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 - 1 10 0 0 0 0 1
stages stages stages s st sta stag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
ACSL4 has acsl4 A AC ACS ACSL BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 , 1 10 0 0 0 0 1
ACSL1 and acsl1 A AC ACS ACSL BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .,, 3 10 0 0 0 0 1
expression was expression e ex exp expr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -. 2 10 0 0 0 0 1
augmented in augmented a au aug augm BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (). 3 10 0 0 0 0 1
expression pattern expression e ex exp expr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 -,(- 4 10 0 0 0 0 1
value: **) value: v va val valu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 :**)(,). 8 10 0 0 0 0 1
Conversely, ACSL1 conversely, C Co Con Conv BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 ,, 2 10 0 0 0 0 1
respectively (S1 respectively r re res resp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 (). 3 10 0 0 0 0 1
Figure 1: figure F Fi Fig Figu BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 :---- 5 10 0 0 0 0 1
3p preserves 3p 3 3p 3p 3p BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 . 1 10 0 0 0 0 1
A) RT-QPCR a) A A) A) A) BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 )-- 3 10 0 0 0 0 1
stages. B) stages. s st sta stag BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .)----- 7 10 0 0 0 0 1
like organoids like l li lik like BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .-(),() 7 10 0 0 0 0 1
plots B. plots p pl plo plot BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 .(,.;*,.;**,.;***,.;****,.) 27 10 0 0 0 0 1
Interestingly, organoids interestingly, I In Int Inte BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,() 3 10 0 0 0 0 1
ACSL4 expression acsl4 A AC ACS ACSL BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 10 0 0 0 0 1
stage, though stage, s st sta stag BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ,. 2 10 0 0 0 0 1
MiR-19b-1-3p keeps mir-19b-1-3p M Mi MiR MiR- BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 ---- 4 10 0 0 0 0 1
MiRNAs expression mirnas M Mi MiR MiRN BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 . 1 10 0 0 0 0 0
our group our o ou our our BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 --- 3 10 0 0 0 0 0
11 11 11 1 11 11 11 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 0 0 0 0
prognosis in prognosis p pr pro prog BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ( 1 10 0 1 0 0 1
to be to t to to to BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -); 3 10 0 1 0 0 1
invasion and invasion i in inv inva BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 [].-, 5 10 0 0 0 0 1
was maintained was w wa was was BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ----( 5 10 0 0 0 0 1
1B). 1B). 1b). 1 1B 1B) 1B). BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 ). 2 10 0 0 0 0 1
Together with together T To Tog Toge BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ---,-()-( 9 10 0 0 0 0 1
isoform) were isoform) i is iso isof BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 )/[]., 6 10 0 0 0 0 1
miRs plus mirs m mi miR miRs BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 --- 3 10 0 0 0 0 1
were found were w we wer were BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 () 2 10 0 0 0 0 1
Metformin decreases metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 - 1 10 0 0 0 0 1
extent as extent e ex ext exte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
WT organoids wt W WT WT WT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
Since Metformin since S Si Sin Sinc BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 10 0 0 0 0 1
recently associated recently r re rec rece BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 10 0 0 0 0 1
phenotype from phenotype p ph phe phen BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 /[]; 4 10 0 0 0 0 1
we wondered we w we we we BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 10 0 0 0 0 1
CRC-like organoids crc-like C CR CRC CRC- BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 -, 2 10 0 0 0 0 1
chemotherapeutic agent chemotherapeutic c ch che chem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 -; 2 10 0 0 0 0 1
upon treatment. upon u up upo upon BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .(), 4 10 0 0 0 0 1
while they while w wh whi whil BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
corresponding to corresponding c co cor corr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 (-).-( 6 10 0 0 0 0 1
µM and µm µ µM µM µM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 )() 3 10 0 0 0 0 1
organoids, while organoids, o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 ,(-). 5 10 0 0 0 0 1
Figure 2: figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 :- 2 10 0 0 0 0 0
chemotherapy without chemotherapy c ch che chem BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 0
12 12 12 1 12 12 12 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 0 0 0 0
MTT cell mtt M MT MTT MTT BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -- 2 10 0 1 0 0 1
like organoids like l li lik like BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ();()/ 6 10 0 1 0 0 1
I; (C) i; I I; I; I; BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 ;()/,/;()/,/,/ 14 10 0 0 0 0 1
organoids resembling organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 ;()/,/,/,/ 10 10 0 0 0 0 1
resembling stage resembling r re res rese BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 .-() 4 10 0 0 0 0 1
except A: except e ex exc exce BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 :().(,.;*,.;**,.;***,.;****,.). 31 10 0 0 0 0 1
Metformin treatment metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
to 5FU to t to to to BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
opposite behavior opposite o op opp oppo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
To further to T To To To BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 10 0 0 0 0 1
reversibility of reversibility r re rev reve BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 10 0 0 0 0 1
was assayed was w wa was was BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (,-) 4 10 0 0 0 0 1
72 additional 72 7 72 72 72 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 6 ., 2 10 0 0 0 0 1
recovery sensitivity recovery r re rec reco BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 10 0 0 0 0 1
almost similar almost a al alm almo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ., 2 10 0 0 0 0 1
organoids recoveries organoids o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
was quite was w wa was was BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (-:***)(). 10 10 0 0 0 0 1
very significantly very v ve ver very BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (-:****)-(-:*), 15 10 0 0 0 0 1
compared to compared c co com comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 ; 1 10 0 0 0 0 1
the Metformin the t th the the BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 -(). 4 10 0 0 0 0 1
stages II-III stages s st sta stag BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 -(),, 5 10 0 0 0 0 1
stage IV stage s st sta stag BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ,-- 3 10 0 0 0 0 1
treated organoids treated t tr tre trea BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ().-() 6 10 0 0 0 0 1
the same the t th the the BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 ()(-). 6 10 0 0 0 0 0
13 13 13 1 13 13 13 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 0
Figure 3: figure F Fi Fig Figu BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 : 1 10 0 1 0 0 1
stages organoids stages s st sta stag BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 0 1 0 0 1
MTT cell mtt M MT MTT MTT BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ()- 3 10 0 0 0 0 1
treatment recovery treatment t tr tre trea BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ()()-() 7 10 0 0 0 0 1
in the in i in in in BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 1 -();()/ 7 10 0 0 0 0 1
organoids resembling organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 ;()/,/;()/ 10 10 0 0 0 0 1
, KRAS , , , , , BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 3 ,/,/;()/,/,/ 12 10 0 0 0 0 1
,Smad4 fl/fl ,smad4 , ,S ,Sm ,Sma BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ,/.-( 5 10 0 0 0 0 1
= 3) = = = = = BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 4 ).(,.;*,.;**,.;***,.;****,.). 29 10 0 0 0 0 1
(F) Organoids (f) ( (F (F) (F) BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 (),-, 5 10 0 0 0 0 1
72h post-treatment 72h 7 72 72h 72h BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 -., 3 10 0 0 0 0 1
bright field. bright b br bri brig BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 6 .(). 4 10 0 0 0 0 1
Since WT since S Si Sin Sinc BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 -( 2 10 0 0 0 0 1
3F), the 3f), 3 3F 3F) 3F), BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 ),., 4 10 0 0 0 0 1
organoids recovered organoids o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
5-FU (Fig 5-fu 5 5- 5-F 5-FU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 -().,() 7 10 0 0 0 0 1
showed an showed s sh sho show BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -. 2 10 0 0 0 0 1
accordance with accordance a ac acc acco BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 ,; 2 10 0 0 0 0 1
less effective less l le les less BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 no 0 10 0 0 0 0 1
treated with treated t tr tre trea BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 -. 2 10 0 0 0 0 1
By way by B By By By BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 , 1 10 0 0 0 0 1
adenocarcinoma sequence. adenocarcinoma a ad ade aden BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 .. 2 10 0 0 0 0 1
aberration makes aberration a ab abe aber BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 ,- 2 10 0 0 0 0 0
cystic morphology cystic c cy cys cyst BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 [,] 3 10 0 0 0 0 0
14 14 14 1 14 14 14 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 0
Metformin action metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 1 0 0 1
overexpressing first overexpressing o ov ove over BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 1 0 0 1
Since stage since S Si Sin Sinc BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
other stages, other o ot oth othe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ,, 2 10 0 0 0 0 1
link between link l li lin link BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 1 /. 2 10 0 0 0 0 1
To this to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 ,,/ 3 10 0 0 0 0 1
metabolic network metabolic m me met meta BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 (). 3 10 0 0 0 0 1
expression was expression e ex exp expr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 - 1 10 0 0 0 0 1
II organoids. ii I II II II BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ., 2 10 0 0 0 0 1
significance, respectively. significance, s si sig sign BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ,. 2 10 0 0 0 0 1
Metformin treatment metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ()., 4 10 0 0 0 0 1
Metformin in metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 , 1 10 0 0 0 0 1
and IV and a an and and BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ().() 5 10 0 0 0 0 1
Metformin treatment. metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 . 1 10 0 0 0 0 1
Figure 4: figure F Fi Fig Figu BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 : 1 10 0 0 0 0 1
organoids and organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 10 0 0 0 0 1
in all in i in in in BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 7 . 1 10 0 0 0 0 1
mRNA expression mrna m mR mRN mRNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 /,(),(), 8 10 0 0 0 0 1
RT-QPCR; and rt-qpcr; R RT RT- RT-Q BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 -;,(),-()- 10 10 0 0 0 0 1
1 (E) 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 8 ()-()(). 8 10 0 0 0 0 1
represented by represented r re rep repr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 -().(,.;*,.; 12 10 0 0 0 0 1
**, P **, * ** **, **, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 **,.;***,.;****,.). 19 10 0 0 0 0 1
The expression the T Th The The BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 -. 2 10 0 0 0 0 0
able to able a ab abl able BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 , 1 10 0 0 0 0 0
15 15 15 1 15 15 15 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 0 0 0 0
differences were differences d di dif diff BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
Metformin treatment metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (-). 4 10 0 1 0 0 1
Metformin, but metformin, M Me Met Metf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,-, 3 10 0 0 0 0 1
LGR5 and lgr5 L LG LGR LGR5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
To further to T To To To BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
marker, LGR5; marker, m ma mar mark BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ,;, 3 10 0 0 0 0 1
Ctnnb-1. Importantly, ctnnb-1. C Ct Ctn Ctnn BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 -.,- 4 10 0 0 0 0 1
organoids series organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ()-()-( 7 10 0 0 0 0 1
4E) mRNAs. 4e) 4 4E 4E) 4E) BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 )., 3 10 0 0 0 0 1
µM 5-FU µm µ µM µM µM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 -(-). 5 10 0 0 0 0 1
Metformin action metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 - 1 10 0 0 0 0 1
Warburg-effect impairement warburg-effect W Wa War Warb BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 - 1 10 0 0 0 0 1
The avidity the T Th The The BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ,, 2 10 0 0 0 0 1
is one is i is is is BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 .,-, 4 10 0 0 0 0 1
product of product p pr pro prod BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .- 2 10 0 0 0 0 1
organoids, reflecting organoids, o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ,,. 3 10 0 0 0 0 1
though 5-FU though t th tho thou BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 10 0 0 0 0 1
organoids (Fig organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 (),, 4 10 0 0 0 0 1
capacity in capacity c ca cap capa BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ,,., 4 10 0 0 0 0 1
Metformin effect metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 -- 2 10 0 0 0 0 1
tumorigenic Warburg tumorigenic t tu tum tumo BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 ,. 2 10 0 0 0 0 1
Figure 5: figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 :- 2 10 0 0 0 0 1
impairement impairement impairement i im imp impa BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 0 0 0 0 1
Bars represent bars B Ba Bar Bars BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 -(), 4 10 0 0 0 0 0
Metformin treatment metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 ()-()' 6 10 0 0 0 0 0
cell-based assay. cell-based c ce cel cell BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 -.-(). 6 10 0 0 0 0 0
16 16 16 1 16 16 16 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 0 0 0 0
Data are data D Da Dat Data BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 -().(,.;*, 10 10 0 1 0 0 1
0.05; **, 0.05; 0 0. 0.0 0.05 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .;**,.;***,.;****,.). 21 10 0 1 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
Organoids seem organoids O Or Org Orga BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 [] 2 10 0 0 0 0 1
employing intestinal employing e em emp empl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 10 0 0 0 0 1
intestinal epithelial intestinal i in int inte BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 []., 4 10 0 0 0 0 1
cancer progression cancer c ca can canc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 , 1 10 0 0 0 0 1
ACSL/SCD protumorigenic acsl/scd A AC ACS ACSL BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 /. 2 10 0 0 0 0 1
We showed we W We We We BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 ---, 4 10 0 0 0 0 1
progressively, in progressively, p pr pro prog BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,-. 3 10 0 0 0 0 1
chemotherapeutic agent chemotherapeutic c ch che chem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 -,,; 4 10 0 0 0 0 1
reduction was reduction r re red redu BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 10 0 0 0 0 1
most susceptible most m mo mos most BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -; 2 10 0 0 0 0 1
or stronger or o or or or BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -,., 4 10 0 0 0 0 1
the intestinal the t th the the BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 10 0 0 0 0 1
downstream targets, downstream d do dow down BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ,--.,- 6 10 0 0 0 0 1
organoids series organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
L-lactate levels; l-lactate L L- L-l L-la BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 -; 2 10 0 0 0 0 1
Warburg effect. warburg W Wa War Warb BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 . 1 10 0 0 0 0 1
The individual the T Th The The BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 [,][,][-] 9 10 0 0 0 0 1
been extensively been b be bee been BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ., 2 10 0 0 0 0 0
the stages the t th the the BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ,, 2 10 0 0 0 0 0
overexpressed in overexpressed o ov ove over BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 . 1 10 0 0 0 0 0
17 17 17 1 17 17 17 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 0 0 0 0
which can which w wh whi whic BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 [] 2 10 0 1 0 0 1
[8]. Nevertheless, [8]. [ [8 [8] [8]. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 []., 4 10 0 0 0 0 1
control the control c co con cont BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 10 0 0 0 0 1
biopsies with biopsies b bi bio biop BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ., 2 10 0 0 0 0 1
sporadic colorectal sporadic s sp spo spor BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 10 0 0 0 0 1
cancer. Due cancer. c ca can canc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ., 2 10 0 0 0 0 1
present in present p pr pre pres BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ., 2 10 0 0 0 0 1
organoids with organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 (), 3 10 0 0 0 0 1
role of role r ro rol role BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 /. 2 10 0 0 0 0 1
range of range r ra ran rang BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 () 2 10 0 0 0 0 1
III and iii I II III III BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 no 0 10 0 0 0 0 1
other undetermined other o ot oth othe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ., 2 10 0 0 0 0 1
compared to compared c co com comp BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .,() 4 10 0 0 0 0 1
could be could c co cou coul BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
explained by explained e ex exp expl BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 () 2 10 0 0 0 0 1
human protein human h hu hum huma BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (),. 4 10 0 0 0 0 1
For its for F Fo For For BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 ,, 2 10 0 0 0 0 1
epithelial ones, epithelial e ep epi epit BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 ,[,] 4 10 0 0 0 0 1
distinctive results distinctive d di dis dist BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 (). 3 10 0 0 0 0 1
Regarding miRs regarding R Re Reg Rega BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 ,----- 6 10 0 0 0 0 1
organoids, also organoids, o or org orga BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 ,,[]. 5 10 0 0 0 0 1
isoform of isoform i is iso isof BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 ---,-,--, 9 10 0 0 0 0 1
miRNA is mirna m mi miR miRN BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 9 ,-[].- 6 10 0 0 0 0 1
17-92 cluster 17-92 1 17 17- 17-9 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 -[,]., 6 10 0 0 0 0 1
interesting the interesting i in int inte BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 , 1 10 0 0 0 0 0
stem cells stem s st ste stem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 .,- 3 10 0 0 0 0 0
also reported also a al als also BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 (), 3 10 0 0 0 0 0
18 18 18 1 18 18 18 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 0 0 0 0
production in production p pr pro prod BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 ' 1 10 0 1 0 0 1
disease, which disease, d di dis dise BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,,[]. 5 10 0 1 0 0 1
Since Metformin since S Si Sin Sinc BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 /, 2 10 0 0 0 0 1
this process this t th thi this BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 10 0 0 0 0 1
Metformin treatment metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 1 -, 2 10 0 0 0 0 1
organoids recovery organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 -. 2 10 0 0 0 0 1
therapies could therapies t th the ther BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 10 0 0 0 0 1
stages rather stages s st sta stag BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 -., 3 10 0 0 0 0 1
patients points patients p pa pat pati BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 []. 3 10 0 0 0 0 1
improbable to improbable i im imp impr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,; 2 10 0 0 0 0 1
we wonder we w we we we BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 10 0 0 0 0 1
representative. representative. representative. r re rep repr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 10 0 0 0 0 1
As well, as A As As As BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 ,, 2 10 0 0 0 0 1
CRC. For crc. C CR CRC CRC. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ., 2 10 0 0 0 0 1
non-diabetic CRC non-diabetic n no non non- BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -.()[]., 8 10 0 0 0 0 1
study of study s st stu stud BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -[], 4 10 0 0 0 0 1
longstanding cancer longstanding l lo lon long BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 ., 2 10 0 0 0 0 1
they also they t th the they BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 , 1 10 0 0 0 0 1
and enhanced and a an and and BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -,[]. 5 10 0 0 0 0 1
Previous reports previous P Pr Pre Prev BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 10 0 0 0 0 1
mechanism of mechanism m me mec mech BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ., 2 10 0 0 0 0 1
compromised upon compromised c co com comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ,. 2 10 0 0 0 0 1
decreases the decreases d de dec decr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 --, 3 10 0 0 0 0 1
decreasing the decreasing d de dec decr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 -(- 3 10 0 0 0 0 0
CoA) and coa) C Co CoA CoA) BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 )() 3 10 0 0 0 0 0
[42]. This [42]. [ [4 [42 [42] BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 [].,/. 6 10 0 0 0 0 0
19 19 19 1 19 19 19 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 0 0 0
downregulation in downregulation d do dow down BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 1 0 0 1
significant in significant s si sig sign BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (,)()., 7 10 0 1 0 0 1
first stages first f fi fir firs BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 ()(); 5 10 0 0 0 0 1
advanced stages, advanced a ad adv adva BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 , 1 10 0 0 0 0 1
effective. This effective. e ef eff effe BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 ., 2 10 0 0 0 0 1
and enhanced and a an and and BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 , 1 10 0 0 0 0 1
Metformin exposure metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 ()., 4 10 0 0 0 0 1
variations in variations v va var vari BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 , 1 10 0 0 0 0 1
expression [43], expression e ex exp expr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 [],,/ 5 10 0 0 0 0 1
besides that besides b be bes besi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
effects upon effects e ef eff effe BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,. 2 10 0 0 0 0 1
Metformin was metformin M Me Met Metf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 , 1 10 0 0 0 0 1
synthesis and synthesis s sy syn synt BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 [];,- 5 10 0 0 0 0 1
carbon chain carbon c ca car carb BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,[], 4 10 0 0 0 0 1
case that case c ca cas case BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 no 0 10 0 0 0 0 1
inhibition by inhibition i in inh inhi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ---- 4 10 0 0 0 0 1
lipids in lipids l li lip lipi BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 [],, 4 10 0 0 0 0 1
detoxifying ACSLs detoxifying d de det deto BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 . 1 10 0 0 0 0 1
Metformin seems metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 []., 4 10 0 0 0 0 1
have described have h ha hav have BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 - 1 10 0 0 0 0 1
Metformin treatment; metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 ;[]. 4 10 0 0 0 0 1
diminished in diminished d di dim dimi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 -, 2 10 0 0 0 0 1
Metformin action metformin M Me Met Metf BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 , 1 10 0 0 0 0 1
organoids lineage. organoids o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 ., 2 10 0 0 0 0 1
necrosis, but necrosis, n ne nec necr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 ,, 2 10 0 0 0 0 0
disappeared and disappeared d di dis disa BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 (), 3 10 0 0 0 0 0
biogenesis is biogenesis b bi bio biog BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ,. 2 10 0 0 0 0 0
20 20 20 2 20 20 20 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 0 0 0
Finally, Metformin finally, F Fi Fin Fina BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 10 0 1 0 0 1
glycolysis. Since glycolysis. g gl gly glyc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ., 2 10 0 0 0 0 1
AMPK is ampk A AM AMP AMPK BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 1 ,; 2 10 0 0 0 0 1
alternative ATP alternative a al alt alte BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 [].- 4 10 0 0 0 0 1
increasing glycolysis increasing i in inc incr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,(); 4 10 0 0 0 0 1
phenotype, especially phenotype, p ph phe phen BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,, 2 10 0 0 0 0 1
this organoids. this t th thi this BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 10 0 0 0 0 1
that Warburg that t th tha that BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 . 1 10 0 0 0 0 1
Even though even E Ev Eve Even BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 , 1 10 0 0 0 0 1
other metabolic other o ot oth othe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
cause of cause c ca cau caus BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 10 0 0 0 0 1
usual stages usual u us usu usua BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 []., 4 10 0 0 0 0 1
be included be b be be be BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 -. 2 10 0 0 0 0 1
Conclusions Conclusions conclusions C Co Con Conc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
General conclusion general G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
1. Organoids 1. 1 1. 1. 1. BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .- 2 10 0 0 0 0 1
suitable for suitable s su sui suit BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 , 1 10 0 0 0 0 1
low costs, low l lo low low BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 9 ,. 2 10 0 0 0 0 1
Metformin-related conclusions metformin-related M Me Met Metf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 - 1 10 0 0 0 0 1
2. Metformin 2. 2 2. 2. 2. BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .: 2 10 0 0 0 0 0
-It is -it - -I -It -It BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 -- 2 10 0 0 0 0 0
chemotherapy (5-FU) chemotherapy c ch che chem BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 (-). 4 10 0 0 0 0 0
21 21 21 2 21 21 21 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 0 0 0
-Metformin treatment -metformin - -M -Me -Met BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -- 2 10 0 1 0 0 1
organoids, but organoids, o or org orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 ,; 2 10 0 0 0 0 1
chemotherapy drug chemotherapy c ch che chem BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 . 1 10 0 0 0 0 1
-Metformin downregulates -metformin - -M -Me -Met BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 - 1 10 0 0 0 0 1
expression in expression e ex exp expr BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 -, 2 10 0 0 0 0 1
cancers. cancers. cancers. c ca can canc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 . 1 10 0 0 0 0 1
-Metformin action -metformin - -M -Me -Met BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 --, 3 10 0 0 0 0 1
presuming that presuming p pr pre pres BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 10 0 0 0 0 1
the cancer the t th the the BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 10 0 0 0 0 1
ACSL/SCD-related conclusions acsl/scd-related A AC ACS ACSL BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 /- 2 10 0 0 0 0 1
3. ACSL4 3. 3 3. 3. 3. BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 .-; 3 10 0 0 0 0 1
miR-19b-1-3p preserves mir-19b-1-3p m mi miR miR- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ---,/ 5 10 0 0 0 0 1
on CRC on o on on on BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 .,- 3 10 0 0 0 0 1
overexpressing first overexpressing o ov ove over BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 10 , 1 10 0 0 0 0 1
stage. stage. stage. s st sta stag BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 10 0 0 0 0 1
22 22 22 2 22 22 22 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 0 0 0 0
Acknowledgment Acknowledgment acknowledgment A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
We kindly we W We We We BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ..- 3 10 0 0 0 0 1
the whole the t th the the BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 , 1 10 0 0 0 0 1
Carl Gustav carl C Ca Car Carl BLOCKEND PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 3 . 1 10 0 0 0 0 1
with the with w wi wit with BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 10 0 0 0 0 1
Conflict of conflict C Co Con Conf BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 10 0 0 0 0 1
Authors declare authors A Au Aut Auth BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 10 0 0 0 0 1
Source of source S So Sou Sour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 no 0 10 0 0 0 0 1
This work this T Th Thi This BLOCKEND PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 no 0 10 0 0 0 0 1
(MINECO, Plan (mineco, ( (M (MI (MIN BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 (,--), 6 10 0 0 0 0 1
Madrid (P2013/ABI-2728, madrid M Ma Mad Madr BLOCKEND PAGEEND NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 10 (/-,-). 7 10 0 0 0 0 1
23 23 23 2 23 23 23 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 0 0 0 0
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
1. Ferlay 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,,,. 8 10 0 0 0 0 1
incidence and incidence i in inc inci BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 :, 2 10 0 0 0 0 1
GLOBOCAN 2012. globocan G GL GLO GLOB BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..;:-.:./. 10 10 0 0 0 0 1
2. Müller 2. 2 2. 2. 2. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,,. 4 10 0 0 0 0 1
colorectal cancer. colorectal c co col colo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ..;:-.:./-- 11 10 0 0 0 0 1
1956-3 1956-3 1956-3 1 19 195 1956 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 1 - 1 10 0 0 0 0 1
3. Yamagishi, 3. 3 3. 3. 3. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 .,.,,.,,.,,.(). 15 10 0 0 0 0 1
of sporadic of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 .,,. 4 10 0 0 0 0 1
http://doi.org/10.1186/s40880-015-0066-y http://doi.org/10.1186/s40880-015-0066-y http://doi.org/10.1186/s40880-015-0066-y h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 8 2 ://././--- 10 10 0 0 0 0 1
4. Fearon 4. 4 4. 4. 4. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .,... 5 10 0 0 0 0 1
1990;61: 759-767. 1990;61: 1 19 199 1990 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 3 ;:-. 4 10 0 0 0 0 1
5. Sánchez-Martínez 5. 5 5. 5. 5. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .-,-,,-, 8 10 0 0 0 0 1
Vargas T, vargas V Va Var Varg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 4 ,,.- 4 10 0 0 0 0 1
mesenchymal transition mesenchymal m me mes mese BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 .. 2 10 0 0 0 0 1
2015;6: 38719-38736. 2015;6: 2 20 201 2015 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 4 ;:-.:./. 8 10 0 0 0 0 1
6. Nasri 6. 6 6. 6. 6. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 .,-.:. 6 10 0 0 0 0 1
Isfahan Univ isfahan I Is Isf Isfa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 .;:-. 5 10 0 0 0 0 1
7. Baglia 7. 7 7. 7. 7. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 10 0 0 0 0 1
Use in use U Us Use Use BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 ,,, 3 10 0 0 0 0 1
Gastric Cancer. gastric G Ga Gas Gast BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 ..; 3 10 0 0 0 0 1
doi:10.4143/crt.2017.591 doi:10.4143/crt.2017.591 doi:10.4143/crt.2017.591 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 :./.. 5 10 0 0 0 0 1
8. Cruz-Gil 8. 8 8. 8. 8. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 .-,-,,-, 8 10 0 0 0 0 1
Vargas T, vargas V Va Var Varg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 7 ,,./ 4 10 0 0 0 0 1
colorectal cancer colorectal c co col colo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 :--. 4 10 0 0 0 0 1
Res. 2018;59: res. R Re Res Res. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 8 .;:-.:./. 9 10 0 0 0 0 1
9. Sato 9. 9 9. 9. 9. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 .,.:.. 6 10 0 0 0 0 1
2015;161: 1700-1700.e1. 2015;161: 2 20 201 2015 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 8 ;:-..:./.... 12 10 0 0 0 0 1
10. Werner 10. 1 10 10. 10. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .,,. 4 10 0 0 0 0 1
Diseases: Tissue diseases: D Di Dis Dise BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 :.. 3 10 0 0 0 0 1
2016;4: 1-9. 2016;4: 2 20 201 2016 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 9 ;:-.:./--- 10 10 0 0 0 0 1
11. Sato 11. 1 11 11. 11. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 .,,,,,,. 8 10 0 0 0 0 1
Single Lgr5 single S Si Sin Sing BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 10 - 1 10 0 0 0 0 1
niche. Nature. niche. n ni nic nich BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 10 ..;:-.:./ 9 10 0 0 0 0 1
12. Golovko 12. 1 12 12. 12. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 11 .,,,. 5 10 0 0 0 0 0
drug discovery. drug d dr dru drug BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 ..;:-. 6 10 0 0 0 0 0
doi:10.1517/17460441.2015.1079618 doi:10.1517/17460441.2015.1079618 doi:10.1517/17460441.2015.1079618 d do doi doi: BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 11 :./.. 5 10 0 0 0 0 0
24 24 24 2 24 24 24 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 0 0 0 0
13. O'Rourke 13. 1 13 13. 13. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .',,,,,,. 9 10 0 1 0 0 1
Transplantation of transplantation T Tr Tra Tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
mouse models mouse m mo mou mous BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ..;:-. 6 10 0 0 0 0 1
doi:10.1038/nbt.3837 doi:10.1038/nbt.3837 doi:10.1038/nbt.3837 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 :./. 4 10 0 0 0 0 1
14. Barker 14. 1 14 14. 14. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,,,,,,. 8 10 0 0 0 0 1
Lgr5(+ve) stem lgr5(+ve) L Lg Lgr Lgr5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ()-- 4 10 0 0 0 0 1
units in units u un uni unit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ..;:-.:./.... 13 10 0 0 0 0 1
15. Boj 15. 1 15 15. 15. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .,-,,,,,. 9 10 0 0 0 0 1
models of models m mo mod mode BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 ..;:-. 6 10 0 0 0 0 1
doi:10.1016/j.cell.2014.12.021 doi:10.1016/j.cell.2014.12.021 doi:10.1016/j.cell.2014.12.021 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 :./.... 7 10 0 0 0 0 1
16. Huch 16. 1 16 16. 16. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,,,,. 8 10 0 0 0 0 1
expansion of expansion e ex exp expa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 -. 2 10 0 0 0 0 1
Nature. 2013;494: nature. N Na Nat Natu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 .;:-.:./ 8 10 0 0 0 0 1
17. Sato 17. 1 17 17. 17. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 .,,,,,,. 8 10 0 0 0 0 1
Long-term expansion long-term L Lo Lon Long BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 -,, 3 10 0 0 0 0 1
adenocarcinoma, and adenocarcinoma, a ad ade aden BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 ,'..;:- 7 10 0 0 0 0 1
1772. doi:10.1053/j.gastro.2011.07.050 1772. 1 17 177 1772 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 .:./.... 8 10 0 0 0 0 1
18. Seidlitz 18. 1 18 18. 18. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,, 7 10 0 0 0 0 1
al. Human al. a al al. al. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 ...; 4 10 0 0 0 0 1
doi:10.1136/gutjnl-2017-314549 doi:10.1136/gutjnl-2017-314549 doi:10.1136/gutjnl-2017-314549 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 :./-- 5 10 0 0 0 0 1
19. Barker 19. 1 19 19. 19. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,,,,,,. 8 10 0 0 0 0 1
Lgr5(+ve) stem lgr5(+ve) L Lg Lgr Lgr5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ()-- 4 10 0 0 0 0 1
units in units u un uni unit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ..;:-.:./.... 13 10 0 0 0 0 1
20. Farin 20. 2 20 20. 20. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 .,,. 4 10 0 0 0 0 1
stem cells stem s st ste stem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ..;: 4 10 0 0 0 0 1
1518-1529.e7. doi:10.1053/j.gastro.2012.08.031 1518-1529.e7. 1 15 151 1518 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 7 -..:./.... 10 10 0 0 0 0 1
21. Andersson-Rolf 21. 2 21 21. 21. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .-,,,,,,.- 10 10 0 0 0 0 1
step generation step s st ste step BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 .. 2 10 0 0 0 0 1
2017;14: 287-289. 2017;14: 2 20 201 2017 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 8 ;:-.:./. 8 10 0 0 0 0 1
22. Bijsmans 22. 2 22 22. 22. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 .,,,,, 6 10 0 0 0 0 1
Jonker JW, jonker J Jo Jon Jonk BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 ,.- 3 10 0 0 0 0 1
organoids as organoids o or org orga BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 . 1 10 0 0 0 0 1
Acta. 2017;1863: acta. A Ac Act Acta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 .;:-.:./.... 12 10 0 0 0 0 1
23. Ciorba 23. 2 23 23. 23. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ..: 3 10 0 0 0 0 1
lipid biology. lipid l li lip lipi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 ..;:-.:./. 10 10 0 0 0 0 1
24. Chen 24. 2 24 24. 24. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .-,-,-,-,-,-. 13 10 0 0 0 0 1
Analysis of analysis A An Ana Anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 - 1 10 0 0 0 0 0
Acyl-Coenzyme A acyl-coenzyme A Ac Acy Acyl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 -..;. 5 10 0 0 0 0 0
doi:10.1371/journal.pone.0155660 doi:10.1371/journal.pone.0155660 doi:10.1371/journal.pone.0155660 d do doi doi: BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 11 :./.. 5 10 0 0 0 0 0
25 25 25 2 25 25 25 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 0 0 0 0
25. Heimerl 25. 2 25 25. 25. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 10 0 1 0 0 1
Alterations in alterations A Al Alt Alte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 10 0 1 0 0 1
Biochim Biophys biochim B Bi Bio Bioc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .;:-.:./.... 12 10 0 0 0 0 1
26. Cao 26. 2 26 26. 26. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,.- 6 10 0 0 0 0 1
in colon in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 1 ..;:-. 6 10 0 0 0 0 1
27. Roongta 27. 2 27 27. 27. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .,,,-,,,. 9 10 0 0 0 0 1
Cancer cell cancer C Ca Can Canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 - 1 10 0 0 0 0 1
desaturase as desaturase d de des desa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 ..;:- 5 10 0 0 0 0 1
1561. doi:10.1158/1541-7786.MCR-11-0126 1561. 1 15 156 1561 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 2 .:./-.-- 8 10 0 0 0 0 1
28. Igal 28. 2 28 28. 28. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 ..-: 4 10 0 0 0 0 1
cancer metabolism. cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..;:-. 6 10 0 0 0 0 1
doi:10.1016/j.bbalip.2016.09.009 doi:10.1016/j.bbalip.2016.09.009 doi:10.1016/j.bbalip.2016.09.009 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 :./.... 7 10 0 0 0 0 1
29. Chen 29. 2 29 29. 29. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,,,,.-- 10 10 0 0 0 0 1
mediated cell mediated m me med medi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 10 0 0 0 0 1
Rep. 2016;6: rep. R Re Rep Rep. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 .;:.:./ 7 10 0 0 0 0 1
30. Ran 30. 3 30 30. 30. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 .,,,,,,.-- 10 10 0 0 0 0 1
promotes colorectal promotes p pr pro prom BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 no 0 10 0 0 0 0 1
PTEN. J pten. P PT PTE PTEN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..;:.:./--- 11 10 0 0 0 0 1
31. Qiu 31. 3 31 31. 31. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 10 0 0 0 0 1
of human of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 10 0 0 0 0 1
Assoc Cancer assoc A As Ass Asso BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 .;:-.:./-.-- 12 10 0 0 0 0 1
32. Lu 32. 3 32 32. 32. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,.- 8 10 0 0 0 0 1
desaturase 1 desaturase d de des desa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 10 0 0 0 0 1
induced endothelial induced i in ind indu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ..;:.:./-- 10 10 0 0 0 0 1
13-53 13-53 13-53 1 13 13- 13-5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 - 1 10 0 0 0 0 1
33. Tao 33. 3 33 33. 33. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,,,,.- 9 10 0 0 0 0 1
desaturase 1 desaturase d de des desa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 8 -. 2 10 0 0 0 0 1
Panminerva Med. panminerva P Pa Pan Panm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 .;:-. 5 10 0 0 0 0 1
34. Wu 34. 3 34 34. 34. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 8 .,,,,,,.-// 11 10 0 0 0 0 1
the self-renewal the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 -..;: 5 10 0 0 0 0 1
4220-4229. doi:10.1242/jcs.127944 4220-4229. 4 42 422 4220 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 -.:./. 6 10 0 0 0 0 1
35. Xiang 35. 3 35 35. 35. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 .,.?-- 6 10 0 0 0 0 1
Tumorigenesis. Curr tumorigenesis. T Tu Tum Tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 ..;:-. 6 10 0 0 0 0 1
doi:10.2174/138920210790886853 doi:10.2174/138920210790886853 doi:10.2174/138920210790886853 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 10 :./ 3 10 0 0 0 0 1
36. Zhang 36. 3 36 36. 36. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,,,,,. 8 10 0 0 0 0 1
high-expression of high-expression h hi hig high BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 ---:- 5 10 0 0 0 0 1
analysis. Sci analysis. a an ana anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 ..;:.:./--- 11 10 0 0 0 0 0
37. Cheng 37. 3 37 37. 37. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 .,,,,,,.- 9 10 0 0 0 0 0
intestinal SOCS3 intestinal i in int inte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 11 '.. 3 10 0 0 0 0 0
2015;5. doi:10.1038/srep10397 2015;5. 2 20 201 2015 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 11 ;.:./ 5 10 0 0 0 0 0
26 26 26 2 26 26 26 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 0 0 0 0
38. Lee 38. 3 38 38. 38. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,. 7 10 0 1 0 0 1
metformin on metformin m me met metf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 10 0 1 0 0 1
Cancer. 2012;131: cancer. C Ca Can Canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .;:-.:./. 9 10 0 0 0 0 1
39. De 39. 3 39 39. 39. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,,,,,,. 8 10 0 0 0 0 1
Metformin and metformin M Me Met Metf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 no 0 10 0 0 0 0 1
2 diabetic 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 1 - 1 10 0 0 0 0 1
diabetic patients. diabetic d di dia diab BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 ..;:-.:./.. 11 10 0 0 0 0 1
40. Miranda 40. 4 40 40. 40. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 .,,,,,,. 8 10 0 0 0 0 1
Phase 2 phase P Ph Pha Phas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 - 1 10 0 0 0 0 1
Refractory Metastatic refractory R Re Ref Refr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ..;:- 5 10 0 0 0 0 1
328.e1. doi:10.1016/j.clcc.2016.04.011 328.e1. 3 32 328 328. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 3 ..:./.... 9 10 0 0 0 0 1
41. Effect 41. 4 41 41. 41. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 3 .-(), 5 10 0 0 0 0 1
oxaliplatin (O) oxaliplatin o ox oxa oxal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 ()().: 6 10 0 0 0 0 1
Clinical Oncology: clinical C Cl Cli Clin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 :,[].[].: 9 10 0 0 0 0 1
http://ascopubs.org/doi/abs/10.1200/jco.2011.29.15_suppl.e13041 http://ascopubs.org/doi/abs/10.1200/jco.2011.29.15_suppl.e13041 http://ascopubs.org/doi/abs/10.1200/jco.2011.29.15_suppl.e13041 h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 10 4 ://.///./.... 13 10 0 0 0 0 1
42. Griss 42. 4 42 42. 42. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,. 8 10 0 0 0 0 1
Antagonizes Cancer antagonizes A An Ant Anta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 10 0 0 0 0 1
Biosynthesis. PLoS biosynthesis. B Bi Bio Bios BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..;:.:./.. 10 10 0 0 0 0 1
43. Yan 43. 4 43 43. 43. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,-,-,,,.-- 11 10 0 0 0 0 1
synthetase in synthetase s sy syn synt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 :. 2 10 0 0 0 0 1
World J world W Wo Wor Worl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 .;:-.:./... 11 10 0 0 0 0 1
44. Ghadge 44. 4 44 44. 44. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,,.- 7 10 0 0 0 0 1
inflammatory and inflammatory i in inf infl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 -- 2 10 0 0 0 0 1
through modulation through t th thr thro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ..;. 4 10 0 0 0 0 1
doi:10.1186/s12263-016-0518-4 doi:10.1186/s12263-016-0518-4 doi:10.1186/s12263-016-0518-4 d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 8 :./--- 6 10 0 0 0 0 1
45. Zabielski 45. 4 45 45. 45. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 8 .,,,,,- 7 10 0 0 0 0 1
Zabielska AU. zabielska Z Za Zab Zabi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 .- 2 10 0 0 0 0 1
resistant muscle. resistant r re res resi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 ..;:-.:./-- 11 10 0 0 0 0 1
46. Metformin 46. 4 46 46. 46. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 .:, 3 10 0 0 0 0 1
Research [Internet]. research R Re Res Rese BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 9 [].[].: 7 10 0 0 0 0 1
http://cancerpreventionresearch.aacrjournals.org/content/5/3/351 http://cancerpreventionresearch.aacrjournals.org/content/5/3/351 http://cancerpreventionresearch.aacrjournals.org/content/5/3/351 h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 1 10 9 ://..//// 9 10 0 0 0 0 1
47. Mogavero 47. 4 47 47. 47. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 .,,,,,,. 8 10 0 0 0 0 1
Metformin transiently metformin M Me Met Metf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 no 0 10 0 0 0 0 1
either AMPK either e ei eit eith BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 ..;:. 5 10 0 0 0 0 1
doi:10.1038/s41598-017-16149-z doi:10.1038/s41598-017-16149-z doi:10.1038/s41598-017-16149-z d do doi doi: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 10 :./--- 6 10 0 0 0 0 1
48. Andrzejewski 48. 4 48 48. 48. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 .,-,,-. 7 10 0 0 0 0 1
mitochondria to mitochondria m mi mit mito BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ..;:. 5 10 0 0 0 0 1
doi:10.1186/2049-3002-2-12 doi:10.1186/2049-3002-2-12 doi:10.1186/2049-3002-2-12 d do doi doi: BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 11 :./--- 6 10 0 0 0 0 0
27 27 27 2 27 27 27 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 0 0 0 0 0
Supporting information supporting S Su Sup Supp BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 10 0 1 0 0 1
S1 Table. s1 S S1 S1 S1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .()-. 5 10 0 0 0 0 1
S2 Table. s2 S S2 S2 S2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .() 3 10 0 0 0 0 1
quantitative real-time quantitative q qu qua quan BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 1 -. 2 10 0 0 0 0 1
S1 Fig. s1 S S1 S1 S1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 1 .- 2 10 0 0 0 0 1
RT-QPCR analysis rt-qpcr R RT RT- RT-Q BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 1 -()() 5 10 0 0 0 0 1
throughout CRC-like throughout t th thr thro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 2 -.-( 4 10 0 0 0 0 1
= 3) = = = = = BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 2 )(,.;*,.;**,.;***,.;****,.) 27 10 0 0 0 0 1
S2 Fig. s2 S S2 S2 S2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 ./- 3 10 0 0 0 0 1
RT-QPCR analysis rt-qpcr R RT RT- RT-Q BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 -- 2 10 0 0 0 0 1
stages of stages s st sta stag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 /:---(),--(), 13 10 0 0 0 0 1
miR-142-5p (C). mir-142-5p m mi miR miR- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 --().-().(,.;*, 15 10 0 0 0 0 1
≤ 0.05; ≤ ≤ ≤ ≤ ≤ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 6 .;**,.;***,.;****,.). 21 10 0 0 0 0 1
S3 Fig. s3 S S3 S3 S3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .--. 4 10 0 0 0 0 1
MTT cell mtt M MT MTT MTT BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 (), 3 10 0 0 0 0 1
Metformin (yellow metformin M Me Met Metf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 (),-()- 7 10 0 0 0 0 1
like organoids like l li lik like BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 :();/ 5 10 0 0 0 0 1
stage I stage s st sta stag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 ();/,/();/, 11 10 0 0 0 0 1
KRAS G12D/WT kras K KR KRA KRAS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 /,/();/, 8 10 0 0 0 0 0
KRAS G12D/WT kras K KR KRA KRAS BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 /,/,/(). 8 10 0 0 0 0 0
28 28 28 2 28 28 28 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 0 0 0 0 0
are represented are a ar are are BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -().(,.;*, 10 10 0 1 0 0 1
≤ 0.05; ≤ ≤ ≤ ≤ ≤ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 0 .;**,.;***,.;****,.). 21 10 0 0 0 0 1
S4 Fig. s4 S S4 S4 S4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 1 .--. 4 10 0 0 0 0 1
MTT cell mtt M MT MTT MTT BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 2 ()- 3 10 0 0 0 0 1
treatment recovery treatment t tr tre trea BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 2 (),(), 6 10 0 0 0 0 1
and 150 and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 -()- 4 10 0 0 0 0 1
stages:: WT stages:: s st sta stag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 3 ::();/();/, 11 10 0 0 0 0 1
KRAS G12D/WT kras K KR KRA KRAS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 /();/,/ 7 10 0 0 0 0 1
,P53 fl/R172H ,p53 , ,P ,P5 ,P53 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 ,/();/,/ 8 10 0 0 0 0 1
,P53 fl/R172H ,p53 , ,P ,P5 ,P53 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ,/,/(). 7 10 0 0 0 0 1
fold-change mean fold-change f fo fol fold BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -().(,.;*,.;**,.; 17 10 0 0 0 0 1
***, P ***, * ** *** ***, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ***,.;****,.). 14 10 0 0 0 0 1
S5 Fig. s5 S S5 S5 S5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 ./(,-- 6 10 0 0 0 0 1
1) upon 1) 1 1) 1) 1) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 )- 2 10 0 0 0 0 1
Expression leveles expression E Ex Exp Expr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 /,(),() 7 10 0 0 0 0 1
and SCD and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ()-;, 5 10 0 0 0 0 1
(D), Axin-2 (d), ( (D (D) (D), BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 (),-()-()-;(), 14 10 0 0 0 0 1
(yellow bars) (yellow ( (y (ye (yel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 (),-().- 8 10 0 0 0 0 1
change mean change c ch cha chan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ().(,.;*,.;**,.;***,.;****, 27 10 0 0 0 0 1
P ≤ p P P P P BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 11 .). 3 10 0 0 0 0 0
29 29 29 2 29 29 29 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 0 0 0 0 0
S6 Fig. s6 S S6 S6 S6 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 . 1 10 0 1 0 0 1
oncologic treatments. oncologic o on onc onco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 2 . 1 10 0 0 0 0 1
Organoids (stage organoids O Or Org Orga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 (), 3 10 0 0 0 0 1
metabolic drugs metabolic m me met meta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 , 1 10 0 0 0 0 1
post-treatment recovery. post-treatment p po pos post BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 -.,. 4 10 0 0 0 0 1
Leica microscope leica L Le Lei Leic BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 (). 3 10 0 0 0 0 1

